ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Feb 17, 2015
Insider Transaction Report
Form 4
Keuer Thomas A
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2015-02-12+13,650→ 13,650 totalExercise: $0.67Exp: 2025-02-11→ Common Stock (13,650 underlying) - Award
Common Stock
2015-02-12+25,350→ 126,626 total
Footnotes (3)
- [F1]Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2013 Equity Incentive Plan (the "Plan"). The RSUs vest in three equal annual installments beginning April 2, 2016, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.
- [F2]Includes 84,200 previously reported shares issued as restricted stock units under the Plan and 17,076 previously reported shares of common stock owned.
- [F3]Grant to the Reporting Person of a stock option under the Plan, vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.